166 related articles for article (PubMed ID: 15085488)
1. An update on the molecular genetics of hepatocellular carcinoma.
Suriawinata A; Xu R
Semin Liver Dis; 2004 Feb; 24(1):77-88. PubMed ID: 15085488
[TBL] [Abstract][Full Text] [Related]
2. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
4. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
Kasai Y; Takeda S; Takagi H
Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
[TBL] [Abstract][Full Text] [Related]
6. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
8. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
10. Pathways and gene expression profiles in hepatocellular carcinoma.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
[TBL] [Abstract][Full Text] [Related]
11. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
12. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma: molecular biology aspects].
Blum HE
Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
[TBL] [Abstract][Full Text] [Related]
15. Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.
Nishida N; Nishimura T; Nagasaka T; Ikai I; Goel A; Boland CR
Cancer Res; 2007 May; 67(10):4586-94. PubMed ID: 17510384
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
17. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
[TBL] [Abstract][Full Text] [Related]
18. Molecular therapy and prevention of hepatocellular carcinoma.
Blum HE
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
[TBL] [Abstract][Full Text] [Related]
19. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
